CXCR3 and rheumatoid arthritis: CXCL10 have also been reported to associate with disease activity in RA patients [33] and blocking of CXCR3 inhibits inflammatory cell infiltration and bone destruction in the joints of mice with collagen-induced arthritis by shifting the Th17/Treg cell balance [34].